Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
RFL | US
-0.05
-3.97%
Healthcare
Biotechnology
30/04/2024
13/04/2026
1.21
1.23
1.24
1.20
Rafael Holdings Inc. holds interests in clinical and early stage pharmaceutical companies and commercial real estate assets in the United States and Israel. It operates in two segments Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat) that is in Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. Rafael Holdings Inc. was incorporated in 2017 and is headquartered in Newark New Jersey.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Price Below SMA10D
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
47.1%1 month
40.2%3 months
50.5%6 months
55.1%-
-
0.56
0.03
0.02
5.39
4.15
-
-70.22M
29.87M
29.87M
-
-18.41K
-
373.20
-63.51
1.84
0.43
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.17
Range1M
0.27
Range3M
0.46
Rel. volume
0.93
Price X volume
57.72K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| NRXBF | NRXBF | Biotechnology | 0.4562 | 32.49M | -2.94% | n/a | 0.00% |
| Alterity Therapeutics Limited | ATHE | Biotechnology | 3.66 | 32.00M | -1.48% | n/a | 1.15% |
| Plus Therapeutics Inc | PSTV | Biotechnology | 5.41 | 31.90M | 12.71% | n/a | -45.04% |
| SciSparc Ltd. Ordinary Shares | SPRC | Biotechnology | 3.065 | 31.74M | -2.70% | n/a | 1.00% |
| Audentes Therapeutics Inc | BOLD | Biotechnology | 1.2 | 31.43M | 6.19% | n/a | 0.47% |
| Kiromic BioPharma Inc | KRBP | Biotechnology | 19.795 | 30.60M | 0.13% | n/a | -258.59% |
| PolyPid Ltd | PYPD | Biotechnology | 4.4 | 29.94M | 2.09% | n/a | 689.01% |
| Reviva Pharmaceuticals Holdings Inc. | RVPH | Biotechnology | 0.869 | 28.76M | 12.73% | n/a | 0.00% |
| Cue Biopharma Inc | CUE | Biotechnology | 0.4723 | 28.44M | -5.90% | n/a | 52.09% |
| Inovio Pharmaceuticals Inc | INO | Biotechnology | 1.09 | 28.30M | 2.83% | n/a | 13.42% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 10.4 | 15.84M | -11.56% | n/a | 204.46% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.8799 | 12.86M | -18.53% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.6 | 11.59M | -0.17% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.33 | 3.40M | -0.75% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.2276 | 2.17M | -10.25% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.07 | 1.14M | -0.96% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 5.39 | 0.53 | Expensive |
| Ent. to Revenue | 4.15 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.56 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 50.51 | 72.80 | Lower Risk |
| Debt to Equity | 0.03 | -1.23 | Expensive |
| Debt to Assets | 0.02 | 0.25 | Cheaper |
| Market Cap | 29.87M | 3.66B | Emerging |